Adeena Musheer: Elad Sharon on the Future of Cancer Care Through Biomarker Research and Immunology
Adeena Musheer, Operations Coordinator and Educational Committee Member at MedNews Week, shared Yan Leyfman’s, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, post on X…
Read the full articleYou might also wanna read
How exercise promotes good health; future doctors focus on food; the origins of cancer: Upstate Medical University's HealthLink on Air for Sunday, Jan. 5, 2020
Interviews with Upstate doctor of physical therapy Karen Kemmis, Upstate medical student Natalie Antosh and cancer researcher Mina Bissell,
How breast cancer is detected and treated; suicide prevention efforts; trying to reduce chemotherapy's side effects: Upstate Medical University's HealthLink on Air for Sunday, Feb. 9, 2020
Interviews with Upstate breast surgery chief Ranjna Sharma, MD; psychiatrists Seetha Ramanathan, MD, from Upstate, and Jay Carruthers, MD, f
Explaining genetic abnormalities; coping with a digital world; refugees’ health needs: Upstate Medical University’s HealthLink on Air for Sunday, Jan. 19, 2020
Interviews with Upstate geneticist Robert Roger Lebel, MD, Le Moyne College professor Renee Downey Hart, PhD, and Upstate physician assistan
A new paraneoplastic biomarker
Dr. Anastasia Zekeridou discusses the main takeaways from her paper on a new paraneoplastic biomarker.
Checkups before surgery; diabetes and COVID-19; a look at cervical cancer: Upstate Medical University's HealthLink on Air for Sunday, March 7, 2021
Interviews with internist Zachary Shepherd, MD; chief of endocrinology, diabetes and metabolism Ruth Weinstock, MD, PhD; and gynecologist Al
A biographer looks at pioneering physician Elizabeth Blackwell; doctors-to-be reflect on Blackwell and their med school experience: Upstate Medical University's HealthLink on Air for Sunday, Jan. 31, 2021
Interviews with biographer Janice Nimura and Upstate medical students Neelima Dosakayala and Sruti Akula
Comments
Sign in to join the conversation.
No comments yet. Be the first.